Meng‐Tian Kang
- Ophthalmology top 0.5%
- Glaucoma and retinal disorders 19
- Retinal Diseases and Treatments 11
- Intraocular Surgery and Lenses 4
-
- Corneal surgery and disorders 32
- Retinal Imaging and Analysis 8
- Retinopathy of Prematurity Studies 4
- Epidemiology top 2%
- Ophthalmology and Visual Impairment Studies 38
-
- Visual perception and processing mechanisms 5
- Journals
- Investigative Ophthalmology & Visual Science (7 papers)British Journal of Ophthalmology (5 papers)PLoS ONE (3 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Meng‐Tian Kang
46 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 75
- Ophthalmology 852
- Radiology, Nuclear Medicine and Imaging 1.1k
- Epidemiology 1.1k
- Public Health, Environmental and Occupational Health 182
- Cognitive Neuroscience 73
Countries citing papers authored by Meng‐Tian Kang
This map shows the geographic impact of Meng‐Tian Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐Tian Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐Tian Kang more than expected).
Fields of papers citing papers by Meng‐Tian Kang
This network shows the impact of papers produced by Meng‐Tian Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐Tian Kang. The network helps show where Meng‐Tian Kang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meng‐Tian Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 6 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2022 | 14 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 3 | |
| 10 | 2020 | 18 | |
| 11 | 2019 | 29 | |
| 12 | 2017 | 2 | |
| 13 | 2017 | 2 | |
| 14 | 2017 | 15 | |
| 15 | 2016 | 34 | |
| 16 | 2016 | 109 | |
| 17 | 2016 | 37 | |
| 18 | 2015 | 31 | |
| 19 | 2014 | 76 | |
| 20 | 2013 | 126 |
About Meng‐Tian Kang
Meng‐Tian Kang is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 50 papers that have together received 1.4k indexed citations. Recurring topics across this work include Ophthalmology and Visual Impairment Studies (38 papers), Corneal surgery and disorders (32 papers), Glaucoma and retinal disorders (19 papers), Retinal Diseases and Treatments (11 papers), Retinal Imaging and Analysis (8 papers), Visual perception and processing mechanisms (5 papers), Retinopathy of Prematurity Studies (4 papers) and Intraocular Surgery and Lenses (4 papers). The work is most often cited by research in Ophthalmology (852 citations), Radiology, Nuclear Medicine and Imaging (1.1k citations) and Epidemiology (1.1k citations). Meng‐Tian Kang has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Shi‐Ming Li, Luo-Ru Liu, Ningli Wang, Siyuan Li, Ningli Wang, Siyan Zhan, He Li, Yunyun Sun, Yipeng Wang and Fengju Zhang. Their work appears in journals such as Investigative Ophthalmology & Visual Science, British Journal of Ophthalmology, PLoS ONE, Scientific Reports and Cochrane Database of Systematic Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.